Aminoglycoside-arginine conjugates that bind TAR RNA: Synthesis, characterization, and antiviral activity

被引:77
作者
Litovchick, A
Evdokimov, AG
Lapidot, A [1 ]
机构
[1] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
关键词
D O I
10.1021/bi9917885
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulation of HIV gene expression is crucially dependent on binding of the trans-activator protein, Tat, to the trans-activation response RNA element, TAR, found at the 5' end of all HIV-I transcripts. Tat-TAR interaction is mediated by a short arginine-rich domain of the protein. Disruption of this interaction could, in theory, create a state of complete viral latency. A new class of small-molecule peptidomimetic TAR RNA binders, conjugates of aminoglycosides and arginine, was recently designed [Litovchick, A., Evdokimov, A. G., and Lapidot, A. (1999) FEES Lett. 445, 73-79]. Two of these compounds, the tri-arginine derivative of gentamicin C (R3G) and the tetra-arginine derivative of kanamycin A (R4K), bind efficiently and specifically to TAR RNA. These compounds display negligible toxicity while being transported and accumulated in cell nuclei. Here we present a detailed synthesis and chemical characterization of the aminoglycoside-arginine conjugates R3G and R4K as well as GB4K, the tetra-gamma-guanidinobutyric derivative of kanamycin A. Their binding sites on TAR RNA were assigned by RNase A, uranyl nitrate, and lead acetate footprinting. The conjugates interact with TAR RNA in the widened major groove, formed by the UCU bulge and the neighboring base pairs of the upper stem portion of TAR, the binding site of tat protein, and Tat-derived peptides (e.g., R52). Our results suggest an additional binding site of R4K and R3G compounds, in the lower stem-bulge region of TAR. The antiviral activity of the conjugates in cultured equine dermal fibroblasts infected with equine infectious anemia virus, used as a model system of HIV-infected cells, is also presented.
引用
收藏
页码:2838 / 2852
页数:15
相关论文
共 67 条
[1]   Structure of HIV-1 TAB RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge [J].
AboulEla, F ;
Karn, J ;
Varani, G .
NUCLEIC ACIDS RESEARCH, 1996, 24 (20) :3974-3981
[2]   THE STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAR RNA REVEALS PRINCIPLES OF RNA RECOGNITION BY TAT PROTEIN [J].
ABOULELA, F ;
KARN, J ;
VARANI, G .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 253 (02) :313-332
[3]   RNA folding and misfolding of the hammerhead ribozyme [J].
Bassi, GS ;
Mollegaard, NE ;
Murchie, AIH ;
Lilley, DMJ .
BIOCHEMISTRY, 1999, 38 (11) :3345-3354
[4]   IONIC INTERACTIONS AND THE GLOBAL CONFORMATIONS OF THE HAMMERHEAD RIBOZYME [J].
BASSI, GS ;
MOLLEGAARD, NE ;
MURCHIE, AIH ;
VONKITZING, E ;
LILLEY, DMJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (01) :45-55
[5]   Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism [J].
Bieniasz, PD ;
Grdina, TA ;
Bogerd, HP ;
Cullen, BR .
MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (07) :4592-4599
[6]   DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes [J].
Boiziau, C ;
Dausse, E ;
Yurchenko, L ;
Toulmé, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12730-12737
[7]   Modified (PNA, 2′-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription [J].
Boulmé, F ;
Freund, F ;
Moreau, S ;
Nielsen, PE ;
Gryaznov, S ;
Toulmé, JJ ;
Litvak, S .
NUCLEIC ACIDS RESEARCH, 1998, 26 (23) :5492-5500
[8]   Solution structure of the HIV-2 TAR-argininamide complex [J].
Brodsky, AS ;
Williamson, JR .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :624-639
[9]  
CABRERA C, 1999, UNPUB AIDS RES HUMAN
[10]   ARGININE-MEDIATED RNA RECOGNITION - THE ARGININE FORK [J].
CALNAN, BJ ;
TIDOR, B ;
BIANCALANA, S ;
HUDSON, D ;
FRANKEL, AD .
SCIENCE, 1991, 252 (5009) :1167-1171